Here’s what you should know:
1. He implanted a device called the Hydrus Microstent.
2. Dr. Endl performed the procedure at the Niagara Falls, N.Y.-based Ambulatory Surgery Center of Niagara.
3. The Hydrus Microstent received FDA approval in August.
More articles on supply chain:
Providers have power to help mistreated surgical equipment makers, study says: 6 insights
Takeda expected to win EU approval for Shire deal — Shareholder vote last hurdle
ASC supply chain tip of the day: Check your data
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
